281 related articles for article (PubMed ID: 12527339)
1. Suppression of tumor necrosis factor-alpha and inducible nitric oxide synthase gene expression by THI 52, a new synthetic naphthyl-benzylisoquinoline alkaloid.
Kang YJ; Lee BK; Lee YS; Seo HG; Park MK; Kim HJ; Pyo HS; Chong WS; Jung HJ; Yun-Choi HS; Lee DH; Chang KC
Biochem Pharmacol; 2003 Feb; 65(3):457-64. PubMed ID: 12527339
[TBL] [Abstract][Full Text] [Related]
2. A synthetic isoquinoline alkaloid, 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (YS 51), reduces inducible nitric oxide synthase expression and improves survival in a rodent model of endotoxic shock.
Kang YJ; Seo SJ; Yun-Choi HS; Lee DH; Kim YM; Chang KC
J Pharmacol Exp Ther; 2002 May; 301(2):561-7. PubMed ID: 11961057
[TBL] [Abstract][Full Text] [Related]
3. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid.
Kim HJ; Tsoyi K; Heo JM; Kang YJ; Park MK; Lee YS; Lee JH; Seo HG; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2007 Feb; 320(2):782-9. PubMed ID: 17108235
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of activation of nuclear factor kappaB is responsible for inhibition of inducible nitric oxide synthase expression by higenamine, an active component of aconite root.
Kang YJ; Lee YS; Lee GW; Lee DH; Ryu JC; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 1999 Oct; 291(1):314-20. PubMed ID: 10490919
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by 2'-hydroxychalcone derivatives in RAW 264.7 cells.
Ban HS; Suzuki K; Lim SS; Jung SH; Lee S; Ji J; Lee HS; Lee YS; Shin KH; Ohuchi K
Biochem Pharmacol; 2004 Apr; 67(8):1549-57. PubMed ID: 15041472
[TBL] [Abstract][Full Text] [Related]
6. Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophages.
Kang YJ; Koo EB; Lee YS; Yun-Choi HS; Chang KC
Br J Pharmacol; 1999 Sep; 128(2):357-64. PubMed ID: 10510445
[TBL] [Abstract][Full Text] [Related]
7. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB.
Whan Han J; Gon Lee B; Kee Kim Y; Woo Yoon J; Kyoung Jin H; Hong S; Young Lee H; Ro Lee K; Woo Lee H
Br J Pharmacol; 2001 Jun; 133(4):503-12. PubMed ID: 11399667
[TBL] [Abstract][Full Text] [Related]
8. Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-kappaB activation.
Kim EJ; Jin HK; Kim YK; Lee HY; Lee SY; Lee KR; Zee OP; Han JW; Lee HW
Biochem Pharmacol; 2001 Apr; 61(7):903-10. PubMed ID: 11274976
[TBL] [Abstract][Full Text] [Related]
9. Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB.
Pingle SC; Sanchez JF; Hallam DM; Williamson AL; Maggirwar SB; Ramkumar V
Mol Pharmacol; 2003 Jun; 63(6):1238-47. PubMed ID: 12761333
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation.
Lee AK; Sung SH; Kim YC; Kim SG
Br J Pharmacol; 2003 May; 139(1):11-20. PubMed ID: 12746218
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Kato H; Imai T; Marumo F; Hirata Y
Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970
[TBL] [Abstract][Full Text] [Related]
12. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases.
Pannu R; Won JS; Khan M; Singh AK; Singh I
J Neurosci; 2004 Jun; 24(26):5942-54. PubMed ID: 15229242
[TBL] [Abstract][Full Text] [Related]
13. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Rim HK; Cho W; Sung SH; Lee KT
J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of pro-inflammatory mediators by a water extract of Schisandra chinensis (Turcz.) Baill fruit in lipopolysaccharide-stimulated RAW 264.7 macrophage cells.
Dilshara MG; Jayasooriya RGPT; Kang CH; Lee S; Park SR; Jeong JW; Choi YH; Seo YT; Jang YP; Kim GY
Environ Toxicol Pharmacol; 2013 Sep; 36(2):256-264. PubMed ID: 23686005
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.
Kang JS; Jeon YJ; Kim HM; Han SH; Yang KH
J Pharmacol Exp Ther; 2002 Jul; 302(1):138-44. PubMed ID: 12065710
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappaB mediates simultaneous induction of inducible nitric-oxide synthase and Up-regulation of the cationic amino acid transporter CAT-2B in rat alveolar macrophages.
Hammermann R; Dreissig MD; Mössner J; Fuhrmann M; Berrino L; Göthert M; Racké K
Mol Pharmacol; 2000 Dec; 58(6):1294-302. PubMed ID: 11093766
[TBL] [Abstract][Full Text] [Related]
17. Nepalolide A inhibits the expression of inducible nitric oxide synthase by modulating the degradation of IkappaB-alpha and IkappaB-beta in C6 glioma cells and rat primary astrocytes.
Wang CN; Shiao YJ; Lin YL; Chen CF
Br J Pharmacol; 1999 Sep; 128(2):345-56. PubMed ID: 10510444
[TBL] [Abstract][Full Text] [Related]
18. Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-kappaB/Rel in lipopolysaccharide-stimulated macrophages.
Jeon YJ; Kim YK; Lee M; Park SM; Han SB; Kim HM
J Pharmacol Exp Ther; 2000 Aug; 294(2):548-54. PubMed ID: 10900231
[TBL] [Abstract][Full Text] [Related]
19. A limited series of synthetic tetrahydroisoquinoline alkaloids reduce inflammatory gene iNOS via inhibition of p-STAT-1 and suppress HMGB1 secretion in LPS-treated mice lung tissue.
Ko YS; Park EJ; Kim YM; Kim HJ; Yun-Choi H; Lee DH; Chang KC
Int Immunopharmacol; 2017 Nov; 52():297-304. PubMed ID: 28982049
[TBL] [Abstract][Full Text] [Related]
20. Heme oxygenase-1 induction by (S)-enantiomer of YS-51 (YS-51S), a synthetic isoquinoline alkaloid, inhibits nitric oxide production and nuclear factor-kappaB translocation in ROS 17/2.8 cells activated with inflammatory stimulants.
Chaea HJ; Kim HR; Kang YJ; Hyun KC; Kim HJ; Seo HG; Lee JH; Yun-Choi HS; Chang KC
Int Immunopharmacol; 2007 Dec; 7(12):1559-68. PubMed ID: 17920533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
